Shao ZM - Search Results

1

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.

Wu SY, Xu Y, Chen L, Fan L, Ma XY, Zhao S, Song XQ, Hu X, Yang WT, Chai WJ, Guo XM, Chen XZ, Xu YH, Zhu XY, Zou JJ, Wang ZH, Jiang YZ, Shao ZM. Wu SY, et al. Among authors: shao zm. Mol Cancer. 2022 Mar 25;21(1):84. doi: 10.1186/s12943-022-01536-6. Mol Cancer. 2022. PMID: 35337339 Free PMC article. Clinical Trial.

2

Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis.

Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, Barsky SH. Shao ZM, et al. Breast Cancer Res Treat. 1999 Feb;53(3):263-9. doi: 10.1023/a:1006194921139. Breast Cancer Res Treat. 1999. PMID: 10369072 Clinical Trial.

3

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.

Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ, Shao ZM. Li HC, et al. Among authors: shao zm. Breast Cancer Res Treat. 2004 Nov;88(1):75-85. doi: 10.1007/s10549-004-1200-8. Breast Cancer Res Treat. 2004. PMID: 15538048

4

Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.

Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM. Zhuang ZG, et al. Among authors: shao zm. Mol Cancer Res. 2006 Nov;4(11):843-9. doi: 10.1158/1541-7786.MCR-06-0118. Mol Cancer Res. 2006. PMID: 17114342

5

Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.

Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Fan L, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Sep;117(2):409-16. doi: 10.1007/s10549-008-0303-z. Epub 2009 Jan 20. Breast Cancer Res Treat. 2009. PMID: 19153831

6

A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.

Yu KD, Di GH, Fan L, Wu J, Hu Z, Shen ZZ, Huang W, Shao ZM. Yu KD, et al. Among authors: shao zm. FASEB J. 2009 Jul;23(7):2274-87. doi: 10.1096/fj.08-124073. Epub 2009 Feb 19. FASEB J. 2009. PMID: 19228880

7

Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.

Yu KD, Di GH, Fan L, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Oct;117(3):675-7. doi: 10.1007/s10549-009-0353-x. Epub 2009 Feb 26. Breast Cancer Res Treat. 2009. PMID: 19242790 No abstract available.

8

Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM. Yu KD, et al. Among authors: shao zm. Hum Mol Genet. 2009 Jul 1;18(13):2502-17. doi: 10.1093/hmg/ddp171. Epub 2009 Apr 7. Hum Mol Genet. 2009. PMID: 19351655

9

Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2.

Yu KD, Di GH, Fan L, Hu Z, Chen AX, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Dec;118(3):647-9. doi: 10.1007/s10549-009-0431-0. Epub 2009 Jun 3. Breast Cancer Res Treat. 2009. PMID: 19495956 No abstract available.

10

Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.

Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast Cancer Res Treat. 2010 May;121(1):157-67. doi: 10.1007/s10549-009-0516-9. Epub 2009 Sep 2. Breast Cancer Res Treat. 2010. PMID: 19728081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters